tetano
Editor, Senior Moderator
J Inflamm Res
. 2024 Mar 2:17:1413-1427.
doi: 10.2147/JIR.S439005. eCollection 2024. Are Changes in Serum IgG Glycosylation Related to the Severe Course of SARS-CoV-2 Infection and Recovery Process? In Search of New Diagnostic and Prognostic Biomarkers
Katarzyna Sołkiewicz[SUP] 1 [/SUP], Izabela Kokot[SUP] 1 [/SUP], Violetta Dymicka-Piekarska[SUP] 2 [/SUP], Justyna Dorf[SUP] 2 [/SUP], Ewa Maria Kratz[SUP] 1 [/SUP]
Affiliations
Introduction: Immunoglobulin G (IgG) glycosylation affects its effector functions and is essential in many steps of the inflammatory cascade. Therefore, it may be an important parameter for assessing the body's immune response during the course of COVID-19 (Coronavirus disease 2019).
Methods: The N- and O-glycosylation of serum IgG in severe COVID-19 patients (n=87), convalescents (n=50), and healthy subjects (n=65) were examined using a modified lectin-ELISA method with specific biotinylated lectins. The obtained data were analyzed using STATISTICA 13.3PL software.
Results: We showed significantly higher expression of Lewis[SUP]x[/SUP] oligosaccharide structures in severe COVID-19 patients than in the other two groups. Moreover, significantly lower expression of Lewis[SUP]y[/SUP] sugar structures in IgG glycans was observed in the convalescents when compared with COVID-19 patients and healthy subjects. The lowest expression of highly branched N-glycans in cases of severe COVID-19 indicates that the development of the disease is associated with the presence of typical IgG biantennary N-glycans. The lack of significant differences in the expression of Tn antigen in IgG between studied groups and the significantly lower expression of T antigen in convalescents compared to the patients with severe COVID-19 and healthy subjects indicates a decrease in the content of the T antigen in IgG O-glycans in subjects recovered from COVID-19. Substantially higher reactivities of IgG O-glycans with Jacalin observed in COVID-19 patients and convalescents in comparison to the control group were most probably caused by increased expression of core 3 O-glycans in IgG.
Conclusion: Severe COVID-19 is accompanied by the expression in serum IgG of sialylated biantennary and highly branched N-glycans, decorated by fucose of Lewis[SUP]x[/SUP] and Lewis[SUP]y[/SUP] structures. The higher reactivity of IgG O-glycans with Jacalin in severe COVID-19 patients and convalescents indicates that the disease development and the recovery process are most probably accompanied by increased expression of the core 3 O-glycans.
Keywords: COVID-19; SARS-CoV-2; glycosylation; inflammation; serum IgG.
. 2024 Mar 2:17:1413-1427.
doi: 10.2147/JIR.S439005. eCollection 2024. Are Changes in Serum IgG Glycosylation Related to the Severe Course of SARS-CoV-2 Infection and Recovery Process? In Search of New Diagnostic and Prognostic Biomarkers
Katarzyna Sołkiewicz[SUP] 1 [/SUP], Izabela Kokot[SUP] 1 [/SUP], Violetta Dymicka-Piekarska[SUP] 2 [/SUP], Justyna Dorf[SUP] 2 [/SUP], Ewa Maria Kratz[SUP] 1 [/SUP]
Affiliations
- PMID: 38450051
- PMCID: PMC10916521
- DOI: 10.2147/JIR.S439005
Introduction: Immunoglobulin G (IgG) glycosylation affects its effector functions and is essential in many steps of the inflammatory cascade. Therefore, it may be an important parameter for assessing the body's immune response during the course of COVID-19 (Coronavirus disease 2019).
Methods: The N- and O-glycosylation of serum IgG in severe COVID-19 patients (n=87), convalescents (n=50), and healthy subjects (n=65) were examined using a modified lectin-ELISA method with specific biotinylated lectins. The obtained data were analyzed using STATISTICA 13.3PL software.
Results: We showed significantly higher expression of Lewis[SUP]x[/SUP] oligosaccharide structures in severe COVID-19 patients than in the other two groups. Moreover, significantly lower expression of Lewis[SUP]y[/SUP] sugar structures in IgG glycans was observed in the convalescents when compared with COVID-19 patients and healthy subjects. The lowest expression of highly branched N-glycans in cases of severe COVID-19 indicates that the development of the disease is associated with the presence of typical IgG biantennary N-glycans. The lack of significant differences in the expression of Tn antigen in IgG between studied groups and the significantly lower expression of T antigen in convalescents compared to the patients with severe COVID-19 and healthy subjects indicates a decrease in the content of the T antigen in IgG O-glycans in subjects recovered from COVID-19. Substantially higher reactivities of IgG O-glycans with Jacalin observed in COVID-19 patients and convalescents in comparison to the control group were most probably caused by increased expression of core 3 O-glycans in IgG.
Conclusion: Severe COVID-19 is accompanied by the expression in serum IgG of sialylated biantennary and highly branched N-glycans, decorated by fucose of Lewis[SUP]x[/SUP] and Lewis[SUP]y[/SUP] structures. The higher reactivity of IgG O-glycans with Jacalin in severe COVID-19 patients and convalescents indicates that the disease development and the recovery process are most probably accompanied by increased expression of the core 3 O-glycans.
Keywords: COVID-19; SARS-CoV-2; glycosylation; inflammation; serum IgG.